10.05Open10.05Pre Close0 Volume26 Open Interest9.00Strike Price0.00Turnover0.00%IV3.93%PremiumJan 17, 2025Expiry Date9.33Intrinsic Value100Multiplier23DDays to Expiry0.72Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pulse Biosciences Stock Discussion
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study With Its Nano-Pfa Cardiac Surgery System
1 MINUTE AGO, 8:00 AM EST
VIA BUSINESSWIRE
No comment yet